FDA
Ouided Rouabhi serves as a Policy Analyst in FDA's Center for Devices and Radiologic Health (CDRH) Office of Clinical Evidence and Analysis (OCEA). Her current role includes providing regulatory guidance to internal and external stakeholders regarding the interpretation and application of policies and procedures related to the Breakthrough Devices and IDE Programs. Prior to joining OCEA, Ouided served as a premarket reviewer in the Office of Cardiovascular Devices where she reviewed cardiac electrophysiology devices, and prior to this, in FDA’s Center for Tobacco Products, where she specialized in electronic cigarette research and policy. Ouided received her M.S. and B.S.E. degrees in Biomedical Engineering from The University of Iowa.
Disclosure information not submitted.
Wednesday, November 17, 2021
1:45 PM – 2:45 PM ET